ZL-1102

· Zai Lab (Hong Kong), Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZL-1102, covering 2024-11-05 to 2024-11-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis [Phase 2]